Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 871-883 , October 2007

Mortality in established rheumatoid arthritis

  • Deborah P.M. Symmons (Professor of Rheumatology and Musculoskeletal Epidemiology)

      Affiliations

    • Corresponding Author InformationCorresponding author. ARC Epidemiology Unit, Stopford Building, University of Manchester, Oxford Road, Manchester, M13 9PT, UK. Tel.: +44 161 275 5044; Fax: +44 161 275 5043.

References 

  1. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. The New England Journal of Medicine. 1953;249(14):553–556
  2. Ropes MW, Bennett GA, Cobb S, et al. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bulletin on the Rheumatic Diseases. 1958;9(4):175–176
  3. Bywaters EGL. 10-year follow-up study of rheumatoid arthritis. Annals of the Rheumatic Diseases. 1961;20:198
  4. Grimstadt-Kvalvik A. Mortality in rheumatoid arthritis. Rheumatology in Europe. 1996;25:9–14
  5. Linos A, Worthington JW, O'Fallon WM, et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. American Journal of Epidemiology. 1980;111(1):87–98
  6. Goodson NJ, Wiles NJ, Lunt M, et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis and Rheumatism. 2002;46(8):2010–2019
  7. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis and Rheumatism. 2003;48(1):54–58
  8. Bjornadal L, Baecklund E, Yin L, et al. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964–95. The Journal of Rheumatology. 2002;29(5):906–912
  9. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Annals of the Rheumatic Diseases. 1999;58(1):11–14
  10. Kroot EJ, Van Leeuwen MA, Van Rijswijk MH, et al. No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Annals of the Rheumatic Diseases. 2000;59(12):954–958
  11. Peltomaa R, Paimela L, Kautiainen H, et al. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Annals of the Rheumatic Diseases. 2002;61(10):889–894
  12. Silman AJ. Trends in the incidence and severity of rheumatoid arthritis. The Journal of Rheumatology. 1992;32(Suppl.):71–73
  13. Ward MM. Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?. Arthritis and Rheumatism. 2001;44(6):1467–1469
  14. Goodson N, Marks J, Lunt M, et al. . Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Annals of the Rheumatic Diseases. 2005;64(11):1595–1601
  15. Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2006;46:350–357
  16. Wicks IP, Moore J, Fleming A. Australian mortality statistics for rheumatoid arthritis 1950–81: analysis of death certificate data. Annals of the Rheumatic Diseases. 1988;47(7):563–569
  17. Mody GM, Meyers OL. Rheumatoid arthritis in blacks in South Africa. Annals of the Rheumatic Diseases. 1989;48(1):69–72
  18. Marques JF, Goncalves HT, Langer LFOB. Prevanence of RA in Brazil. A Multicenter study. Revista Espanola De Reumatologia. 2006;1993(20 (Suppl. 1)):152
  19. Hameed K, Gibson T, Kadir M, et al. The prevalence of rheumatoid arthritis in affluent and poor urban communities of Pakistan. British Journal of Rheumatology. 1995;34(3):252–256
  20. Darmawan J, Muirden KD, Valkenburg HA, et al. The epidemiology of rheumatoid arthritis in Indonesia. British Journal of Rheumatology. 1993;32(7):537–540
  21. Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scandinavian Journal of Rheumatology. 1981;10(4):301–306
  22. Symmons DP, Jones MA, Scott DL, et al. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. The Journal of Rheumatology. 1998;25(6):1072–1077
  23. Symmons D, Bruce I. Management of cardiovascular risk in RA and SLE. Arthritis Research Campaign. Reports on the Rheumatic Diseases. Series 5. 2006;Hands On 8; February 2006
  24. Uddin J, Kraus AS, Kelly HG. Survivorship and death in rheumatoid arthritis. Arthritis and Rheumatism. 1970;13(2):125–130
  25. Mutru O, Laakso M, Isomaki H, et al. Ten year mortality and causes of death in patients with rheumatoid arthritis. British Medical Journal (Clinical Research Ed.). 1985;290(6484):1797–1799
  26. Cathcart ES, Spodick DH. Rheumatoid heart disease. A study of the incidence and nature of cardiac lesions in rheumatoid arthritis. The New England Journal of Medicine. 1962;266:959–964
  27. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. The Journal of Rheumatology. 1997;24(3):445–451
  28. Solomon DH, Goodson NJ, Katz JN, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2006;65(12):1608–1612
  29. Goodson NJ, Symmons DP, Scott DG, et al. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis and Rheumatism. 2005;52(8):2293–2299
  30. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis and Rheumatism. 2005;52(3):722–732
  31. Farragher TM, Lunt M, Bunn DK, et al. Early functional disability predicts both all cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register. Annals of the Rheumatic Diseases. 2007;66:486–492
  32. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis and Rheumatism. 1994;37(4):481–494
  33. Pincus T, Keysor J, Sokka T, et al. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. The Journal of Rheumatology. 2004;31(2):229–234
  34. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis and Rheumatism. 2005;52(2):402–411
  35. Heliovaara M, Aho K, Knekt P, et al. Rheumatoid factor, chronic arthritis and mortality. Annals of the Rheumatic Diseases. 1995;54(10):811–814
  36. Glennas A, Kvien TK, Andrup O, et al. Recent onset arthritis in the elderly: a 5 year longitudinal observational study. The Journal of Rheumatology. 2000;27(1):101–108
  37. Chehata JC, Hassell AB, Clarke SA, et al. Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford). 2001;40(4):447–452
  38. Corbett M, Dalton S, Young A, et al. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. British Journal of Rheumatology. 1993;32(8):717–723
  39. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis?. Rheumatic Diseases Clinics of North America. 1993;19(1):123–151
  40. Lehtinen K, Isomaki H. Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. The Journal of Rheumatology. 1991;18(4):524–529
  41. Choi HK, Hernan MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359(9313):1173–1177
  42. Krause D, Schleusser B, Herborn G, et al. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis and Rheumatism. 2000;43(1):14–21
  43. Hurlimann D, Forster A, Noll G, et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106(17):2184–2187
  44. Jacobsson LT, Turesson C, Gulfe A, et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. The Journal of Rheumatology. 2005;32(7):1213–1218
  45. Maxwell SR, Webb DJ. Cox-2 selective inhibitors–important lessons learned. Lancet. 2005;365(9458):449–451
  46. Duthie JJ, Brown PE, Truelove LH, et al. Course and prognosis in rheumatoid arthritis. A further report. Annals of the Rheumatic Diseases. 1964;23:193–204
  47. Monson RR, Hall AP. Mortality among arthritics. Journal of Chronic Diseases. 1976;29(7):459–467
  48. Lewis P, Hazleman BL, Hanka R, et al. Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Annals of the Rheumatic Diseases. 1980;39(5):457–461
  49. Allebeck P. Increased mortality in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 1982;11(2):81–86
  50. Prior P, Symmons DP, Scott DL, et al. Cause of death in rheumatoid arthritis. British Journal of Rheumatology. 1984;23(2):92–99
  51. Mitchell DM, Spitz PW, Young DY, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis and Rheumatism. 1986;29(6):706–714
  52. Myllykangas-Luosujarvi R, Aho K, Kautiainen H, et al. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clinical and Experimental Rheumatology. 1995;13(2):149–153
  53. Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades?. The Journal of Rheumatology. 1999;26(12):2529–2533
  54. Wolfe F, Hawley DJ, Anderson J. All cause and cause specific mortality in RA: a 25 year study of 1865 RA patients. Arthritis and Rheumatism. 1999;42(September 9 (Suppl.)):S135–S385
  55. Jacobsson LTH, Knowler WC, Pillemer S, et al. Rheumatoid arthritis and mortality - a longitudinal study in Pima Indians. Arthritis Rheum. 1993;36:1045–1053

PII: S1521-6942(07)00058-7

doi: 10.1016/j.berh.2007.05.003

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 871-883 , October 2007

Article Tools